← Back to Search

Digital Social Game for Smoking Cessation

N/A
Recruiting
Led By Jamie Rosen
Research Sponsored by WayBetter, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least 21 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months follow-up from the start of their first quitbet game
Awards & highlights

Study Summary

This trial is testing whether a digital game that offers financial incentives to quit smoking will be more effective than a similar game without the social elements.

Who is the study for?
This trial is for U.S. residents who are at least 21 years old, currently smoke 5+ cigarettes daily, and own a compatible smartphone. Participants must speak English well enough for study procedures, have an email address, be willing to make a $30 deposit, and accept financial incentives via PayPal or check.Check my eligibility
What is being tested?
QuitBet Phase II tests a digital game that combines social elements with financial incentives to help people stop smoking. It's an RCT where participants bet their own money and those who quit smoking win the pot. The study compares QuitBet with its social features against QuitBet-NS without them.See study design
What are the potential side effects?
Since this trial involves no medical interventions but rather uses a digital social game as treatment, there are no direct physical side effects associated with traditional clinical trials.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am at least 21 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months follow-up from the start of their first quitbet game
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months follow-up from the start of their first quitbet game for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
7-day point prevalence abstinence from combustible tobacco use
Secondary outcome measures
proportion of participants who choose to play a second game
proportion of participants who use smoking cessation medication
smoking heaviness

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: QuitBetExperimental Treatment2 Interventions
QuitBet is a quit smoking game delivered via a smartphone application that lasts 28 days and includes contingency management in the form of a deposit contract, integrated exhaled breath carbon monoxide (CO) testing, a social feed on which "players" can post and respond to messages, and a "leaderboard" that displays players' status (i.e., whether they are still eligible to win). A game host will post educational information about smoking cessation and serve as a discussion moderator. Participants will deposit ("bet") $30 of their own money at the start of the game. Participants who submit a CO test that is 6ppm or lower (indicating no smoking) on at least 24 of the 26 days between day 3-28 will be declared winners and will split the pot of money that was deposited. All participants who submit at least 21 CO tests during the 28 day game, regardless of the CO test result, will be entered into a lottery to win a prize worth $75.
Group II: QuitBet-NS (no social elements)Active Control2 Interventions
QuitBet-NS will include the deposit contract and integrated CO testing with identical rules to QuitBet for being a winner, the $75 raffle for submitting at least 21 CO tests, a display of the participant's daily CO test results that is updated in real time, and a game feed on which only the game host has the ability to post. Players will not be able to post on this feed or respond to the host's posts. At the beginning of the game, the host will post limited information, including a list of smoking cessation resources. QuitBet-NS will NOT include the social feed, leaderboard, or any other social features.

Find a Location

Who is running the clinical trial?

WayBetter, Inc.Lead Sponsor
Hennepin Healthcare Research InstituteOTHER
90 Previous Clinical Trials
76,627 Total Patients Enrolled
Jamie RosenPrincipal InvestigatorWayBetter, Inc.

Media Library

Smoking Cessation Research Study Groups: QuitBet, QuitBet-NS (no social elements)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are currently being administered the experimental treatment?

"Affirmative. According to the data displayed on clinicaltrials.gov, this investigation is currently enrolling patients and requires 550 individuals from a single location; it was initially posted on 11/1/2021 and its details were last updated on 11/22/2022."

Answered by AI

Are there currently opportunities for participants in this clinical experiment?

"Correct. Clinicaltrials.gov affirms that this medical evaluation is actively searching for participants, with the initial posting being on November 1st 2021 and a subsequent update occurring around November 22nd 2022."

Answered by AI

Who else is applying?

What state do they live in?
California
Texas
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

It might really help me stop smoking.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
QuitBet Phase II: A Digital Social Game That Pays You to Stop Smoking
2021. "QuitBet Phase II: A Digital Social Game That Pays You to Stop Smoking". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05075213.
~161 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top